Nicotine and Other Tobacco Compounds in Neurodegenerative and Psychiatric Diseases Overview of Epidemiological Data on Smoking and Preclinical and Clinical Data on Nicotine
Auteurs : Veljkovic Emilija, Xia Wenhao, Phillips Blaine, Wong Ee Tsin, Ho Jenny, Oviedo Casado Alberto, Hoeng Julia, Peitsch Manuel C.
Nicotine and Other Tobacco Compounds in Neurodegenerative and Psychiatric Diseases: Epidemiological Data on Smoking and Preclinical and Clinical Data on Nicotine provides a comprehensive summary of the epidemiological data on smoking and several neurological disorders, including Alzheimer?s disease, Parkinson?s disease, Multiple Sclerosis, Tourette?s syndrome, schizophrenia, anxiety, depression and ADHD, as well as preclinical and clinical data on the effects of nicotine. Despite the obvious and undisputed harmful nature of smoking, evidence suggests that some tobacco and tobacco smoke-derived constituents may offer neuroprotective effects, possibly in combinations, rather than individually.
This unprecedented book describes the complex relationships between smoking and neurological disease and the bioactive compounds found in tobacco. It provides a comprehensive review of nicotine and other compounds found in tobacco plant, with scientific evidence of neuroprotective and anti-inflammatory effects that may act in conjunction with nicotine to exert neuroprotective effects observed in smokers.
By presenting findings beyond harmful cigarette smoke effects, attention can be drawn to individual compounds of tobacco that may serve as inspiration for further therapy development.
1. Multiple sclerosis2. Parkinson’s disease3. Alzheimer's disease4. Tourette syndrome5. Attention Deficit Hyperactivity Disorder in children and adults6. Schizophrenia7. Depression8. Anxiety9. Active principles from tobacco or smoke10. Animal and cellular models of MS, AD and PD and major consideration for translatability11. Conclusion remarks12. References
Dr. Xia is Scientist - Study Management at Phillip Morris International Laboratories with experience in drug discovery for neurodegenerative diseases. He has a profound understanding of molecular mechanisms of neurodegeneration in preclinical in vivo models and holds a BSc in life sciences and a PhD in neurobiology.
Dr. Phillips is Senior Scientist - Study Management at Phillip Morris International in Singapore. His research group is focused on late-stage biological assessment of next generation reduced-harm tobacco products within the framework of the R&D department. He is an expert in inhalation toxicology and modeling of smoking-related diseases using systems toxicology approaches. He has ten years’ experience in biotechnology and the pharmaceutical industry, and a thorough understanding of nicotine-related toxicity in animal models. Dr. Phillips holds a BSc in molecular biology and a PhD in medical science.
Dr. Wong is Senior Scientist - Study Management and has 4 years of experience in tobacco industry, focused on O
- Presents the first comprehensive, tabulated summary of literature on the epidemiological data on smoking and neurological disease
- Includes preclinical and clinical data on nicotine in neurological diseases and mechanisms of action of nicotine in neuroprotection
- Features a comprehensive summary of non-nicotine smoke constituents with potentially neuroprotective and anti-inflammatory properties
- Discusses Multiple Sclerosis, Alzheimer’s disease, Parkinson’s Disease, Schizophrenia, Depression, ADHD, Anxiety and Tourette’s Syndrome in the context of smoking and nicotine
Date de parution : 01-2018
Ouvrage de 164 p.
15x22.8 cm
Thèmes de Nicotine and Other Tobacco Compounds in... :
Mots-clés :
ADHD; Adults; Alzheimer' Antidepressant; Anxiety; Attention deficit hyperactivity disorder; Children; CNS; Cognitive functions; Delusions; Dementia; Depression; EAE model; GABA; Generalized anxiety disorder; Hallucinations; hiPSCs; Hyperactivation; Mitochondria; Molecular signaling; Monoamine Âoxidase; Multiple sclerosis; Myelin; nAChR; nAChRs; Neurodegeneration; Neurodegenerative diseases; Neuroinflammation; Neuroprotection; Neurotransmitter systems; Nicotine; Oligodendrocytes; Parkinson's disease; Pathological processes; Prepulse inhibition; s disease; Schizophrenia; Separation anxiety disorder; Smoking; Snus; Social anxiety disorder; Symptoms; T-cells; Tics; Tobacco; Tourette syndrome